Toll-like receptor 4 contributes to the inhibitory effect of morphine on colonic motility in vitro and in vivo

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Farzi, Aitak ^a   Halicka, Juraj ^a,b,c   Mayerhofer, Raphaela ^a   Fröhlich, Esther E ^a   Tatzl, Eva ^a   Holzer, Peter ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b University Hospital in Martin   (Slovakia)

^c FACULTY HOSPITAL   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4;

ANIMAL; ANTAGONISTS AND INHIBITORS; COLON; DRUG EFFECTS; GASTROINTESTINAL MOTILITY; GUINEA PIG; MALE; METABOLISM; MOUSE; SIGNAL TRANSDUCTION;

ANIMALS; COLON; GASTROINTESTINAL MOTILITY; GUINEA PIGS; MALE; MICE; MORPHINE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84929156765     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09499     Document Type: Article

References (50)

1. Holzer, P. Pharmacology of Opioids and their Effects on Gastrointestinal Function. Am J Gastroenterol Suppl 2, 9-16 (2014).
2. DeHaven-Hudkins, D. L., DeHaven, R. N., Little, P. J. & Techner, L. M. The involvement of the mu-opioid receptor in gastrointestinal pathophysiology: therapeutic opportunities for antagonism at this receptor. Pharmacol. Ther. 117, 162-187 (2008).
3. Kumar, L., Barker, C. & Emmanuel, A. Opioid-induced constipation: pathophysiology, clinical consequences, and management. Gastroenterol. Res. Pract. 2014, 141737 (2014).
4. Kalso, E., Edwards, J. E., Moore, R. A. & McQuay, H. J. Opioids in chronic noncancer pain: systematic review of efficacy and safety. Pain 112, 372-380 (2004).
5. Bell, T. J. et al. The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1). Pain Med. 10, 35-42 (2009).
6. Satoh, M. & Minami, M. Molecular pharmacology of the opioid receptors. Pharmacol. Ther. 68, 343-364 (1995).
7. Akira, S.&Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511 (2004).
8. Hutchinson, M. R. et al. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav. Immun. 24, 83-95 (2010).
9. Hutchinson, M. R. et al. Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur. J. Neurosci. 28, 20-29 (2008).
10. Hutchinson, M. R. et al. Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Pharmacol. Rev. 63, 772-810 (2011).
11. Wang, X. et al. Morphine activates neuroinflammation in a manner parallel to endotoxin. Proc. Natl. Acad. Sci. U. S. A. 109, 6325-6330 (2012).
12. Meng, J. et al.Morphine induces bacterial translocation in mice by compromising intestinal barrier function in a TLR-dependent manner. PLoS One 8, e54040 (2013).
13. Buchholz, B. M., Chanthaphavong, R. S. & Bauer, A. J. Nonhemopoietic cell TLR4 signaling is critical in causing early lipopolysaccharide-induced ileus. J. Immunol. 183, 6744-6753 (2009).
14. Rumio, C. et al. Activation of smooth muscle and myenteric plexus cells of jejunum via Toll-like receptor 4. J. Cell. Physiol. 208, 47-54 (2006).
15. Barajon, I. et al. Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia. J. Histochem. Cytochem. 57, 1013-1023 (2009).
16. De Winter, B. Y. & De Man, J. G. Interplay between inflammation, immune system and neuronal pathways: effect on gastrointestinal motility. World J. Gastroenterol. 16, 5523-5535 (2010).
17. Ii, M. et al. A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4- fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling. Mol. Pharmacol. 69, 1288-1295 (2006).
18. Kawamoto, T., Ii, M., Kitazaki, T., Iizawa, Y. & Kimura, H. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain. Eur. J. Pharmacol. 584, 40-48 (2008).
19. Takashima, K. et al. Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model. Br. J. Pharmacol. 157, 1250-1262 (2009).
20. Matsunaga, N., Tsuchimori, N., Matsumoto, T. & Ii, M. TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules. Mol. Pharmacol. 79, 34-41 (2011).
21. Kuno, M. et al. The novel selective toll-like receptor 4 signal transduction inhibitor tak-242 prevents endotoxaemia in conscious Guinea-pigs. Clin. Exp. Pharmacol. Physiol. 36, 589-593 (2009).
22. Sanger, G. J. & Wardle, K. A. Constipation evoked by 5-HT3-receptor antagonism: evidence for heterogeneous efficacy among different antagonists in guinea-pigs. J. Pharm. Pharmacol. 46, 666-670 (1994).
23. Roy, S., Liu, H. C. & Loh, H. H. mu-Opioid receptor-knockout mice: the role of mu-opioid receptor in gastrointestinal transit. Brain Res. Mol. Brain Res. 56, 281-283 (1998).
24. Mori, T. et al. Mechanisms that underlie mu-opioid receptor agonist-induced constipation: differential involvement of mu-opioid receptor sites and responsible regions. J. Pharmacol. Exp. Ther. 347, 91-99 (2013).
25. Goldstein, A., Lowney, L. I. &Pal, B. K. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proc. Natl. Acad. Sci. U. S. A. 68, 1742-1747 (1971).
26. Banerjee, S. et al. Morphine induced exacerbation of sepsis is mediated by tempering endotoxin tolerance through modulation of miR-146a. Sci. Rep. 3, 1977 (2013).
27. Buchholz, B. M. & Bauer, A. J. Membrane TLR signaling mechanisms in the gastrointestinal tract during sepsis. Neurogastroenterol. Motil. 22, 232-245 (2010).
28. Buchholz, B. M., Billiar, T. R. & Bauer, A. J. Dominant role of the MyD88- dependent signaling pathway inmediating early endotoxin-induced murine ileus. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G531-8 (2010).
29. Anitha, M., Vijay-Kumar, M., Sitaraman, S. V., Gewirtz, A. T. & Srinivasan, S. Gut microbial products regulate murine gastrointestinal motility via Toll-like receptor 4 signaling. Gastroenterology 143, 1006-16.e4 (2012).
30. De Winter, B. Y. et al. Involvement of afferent neurons in the pathogenesis of endotoxin-induced ileus in mice: role of CGRP and TRPV1 receptors. Eur. J. Pharmacol. 615, 177-184 (2009).
31. Philippe, D. et al.Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation. J. Clin. Invest. 111, 1329-1338 (2003).
32. Brosnahan, A. J., Jones, B. J., Dvorak, C. M. & Brown, D. R. Morphine attenuates apically-directed cytokine secretion from intestinal epithelial cells in response to enteric pathogens. Pathogens 3, 249-257 (2014).
33. Ortega-Cava, C. F. et al. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J. Immunol. 170, 3977-3985 (2003).
34. Ono, H. et al. Circular muscle contraction in the mice rectum plays a key role in morphine-induced constipation. Neurogastroenterol. Motil. 26, 1396-1407 (2014).
35. Shanahan, F. The colonic microbiota in health and disease. Curr. Opin. Gastroenterol. 29, 49-54 (2013).
36. Boue, J. et al. Endogenous regulation of visceral pain via production of opioids by colitogenic CD4(1) T cells in mice. Gastroenterology 146, 166-175 (2014).
37. Holzer, P. & Farzi, A. Neuropeptides and the microbiota-gut-brain axis. Adv. Exp. Med. Biol. 817, 195-219 (2014).
38. Stevens, C. W., Aravind, S., Das, S. & Davis, R. L. Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4. Br. J. Pharmacol. 168, 1421-1429 (2013).
39. Franchi, S. et al. Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages. Brain Behav. Immun. 26, 480-488 (2012).
40. Langsdorf, E. F., Mao, X. & Chang, S. L. A role for reactive oxygen species in endotoxin-induced elevation of MOR expression in the nervous and immune systems. J. Neuroimmunol. 236, 57-64 (2011).
41. Lefkowitz, R. J. & Shenoy, S. K. Transduction of receptor signals by beta-arrestins. Science 308, 512-517 (2005).
42. Raehal, K. M., Walker, J. K. & Bohn, L. M. Morphine side effects in beta-arrestin 2 knockout mice. J. Pharmacol. Exp. Ther. 314, 1195-1201 (2005).
43. Raehal, K. M. et al. Morphine-induced physiological and behavioral responses in mice lacking G protein-coupled receptor kinase 6. Drug Alcohol Depend. 104, 187-196 (2009).
44. Loniewski, K., Shi, Y., Pestka, J. & Parameswaran, N. Toll-like receptors differentially regulate GPCR kinases and arrestins in primary macrophages. Mol. Immunol. 45, 2312-2322 (2008).
45. Shahbazian, A. et al. Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine. Br. J. Pharmacol. 135, 741-750 (2002).
46. Foxx-Orenstein, A. E., Jin, J. G. & Grider, J. R. 5-HT4 receptor agonists and deltaopioid receptor antagonists act synergistically to stimulate colonic propulsion. Am. J. Physiol. 275, G979-83 (1998).
47. Wang, Y. C. et al. Toll-like receptor 4 antagonist attenuates intracerebral hemorrhage-induced brain injury. Stroke 44, 2545-2552 (2013).
48. Pol, O., Valle, L., Sanchez-Blazquez, P., Garzon, J. & Puig, M. M. Antibodies and antisense oligodeoxynucleotides to mu-opioid receptors, selectively block the effects of mu-opioid agonists on intestinal transit and permeability in mice. Br. J. Pharmacol. 127, 397-404 (1999).
49. Nezami, B. G. et al. MicroRNA 375 mediates palmitate-induced enteric neuronal damage and high-fat diet-induced delayed intestinal transit in mice. Gastroenterology 146, 473-83.e3 (2014).
50. Nagakura, Y., Naitoh, Y., Kamato, T., Yamano, M. & Miyata, K. Compounds possessing 5-HT3 receptor antagonistic activity inhibit intestinal propulsion in mice. Eur. J. Pharmacol. 311, 67-72 (1996).